Baxter International Inc (NYSE:BAX)
$ 33.9 -0.1 (-0.29%) Market Cap: 17.27 Bil Enterprise Value: 28.42 Bil PE Ratio: 6.52 PB Ratio: 2.11 GF Score: 75/100

Baxter International Inc at Barclays Global Healthcare Conference Transcript

Mar 17, 2022 / 12:00PM GMT
Release Date Price: $79.44 (+0.61%)
Luke England Sergott
Barclays Bank PLC, Research Division - Research Analyst

Good morning, everybody. Luke Sergott, I'm the life science tools and diagnostics analyst at Barclays. Kind of pitching over here into the med device side and talking to Jay Saccaro and Clare Trachtman of Baxter. We're going to dig in here. But just to kick it off, if you guys want to do -- open up with a few things to say and then we can dig into questions.

James K. Saccaro
Baxter International Inc. - Executive VP & CFO

Sure, Luke. Thanks for the invitation to the conference. Thanks for pitching in here, pinch-hitting. We appreciate you doing that. And it's nice to see everybody in person. It's hard to believe that we haven't been at this conference for several years. And -- but it is great to be back in person, with seeing a lot of folks that we haven't seen in so many years in person. So that's great.

And I think that for me, as I reflect back on the last couple of years, really pleased with the progress of our company. I mean, I think even more than that, the

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot